Asthma is a common chronic inflammatory disease of the respiratory system that significantly affects the quality of life and overall health of patients. When asthma is poorly managed, the risk of exacerbation and hospitalization increases, leading to higher direct and indirect healthcare costs and reduced productivity. Overuse of short-acting beta-agonists (SABAs) and underuse of inhaled corticosteroids (ICS) often result in poor asthma control and ineffective treatment. To reduce the frequency of exacerbation and alleviate pressure on Kuwait's healthcare system, it is important that patients are discharged with an evidence-based treatment plan.

Asthma

SABA

ICS

Kuwait

Evidence-based

Discharge

© 2025 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.